返回搜索用邮件客户端发送给 dengzhh58@mail.sysu.edu.cn
正在招募III 期编号 NCT07137832
OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion
报名条件(概要)
- 年龄:18 Years – 不限
- 性别:不限
- 健康志愿者:不接受
完整入排标准请以官方页面为准。
开展国家/地区
China
研究药物 / 干预措施
Primary intra-arterial thrombolysis、Standard medical treatment
申办方
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
研究简介(原文)
PEARL-MeVO is an investigator-initiated, multicenter, prospective, randomized controlled, open-label, blinded endpoint (PROBE) clinical trial aiming at evaluating the efficacy and safety of primary intra-arterial thrombolysis in improving 90-day functional outcome in acute ischemic stroke patients due to medium vessel occlusion (MeVO) within 24 hours of symptom onset.
适应症
Acute Ischemic Stroke
主动联系研究团队
总联系人(申办方/研究总部)
- Zhenhong Dengdengzhh58@mail.sysu.edu.cn86-20-81332619
- Xinguang Yangyangxinguang0926@163.com86-20-81332619
中国/港澳台研究中心
- Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangzhou,Guangdong,China
问自己是否符合条件、如何预筛
我的病情档案
档案只保存在您自己的浏览器里,不会上传,任何人(包括本站)都看不到。
英文版(发给研究团队)
Dear Study Team, I am a patient in China and I am interested in participating in your clinical trial: Study Title: OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion ClinicalTrials.gov Identifier: NCT07137832 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Investigational product: Primary intra-arterial thrombolysis, Standard medical treatment About me: - Age: (please fill in) - Sex: (please fill in) - Confirmed diagnosis and stage: (please fill in) - Biomarkers / genetic testing: not available - Prior and current treatments: (please fill in) - Performance status (ECOG): not assessed - Current location: China - Travel ability: (please fill in) Could you please let me know: 1. Whether I might be eligible for this study; 2. Which site would be closest and most practical for me, and whether remote pre-screening is possible; 3. What documents (medical records, pathology or imaging reports, recent labs) I should prepare for pre-screening. I can provide English translations of my medical records. Thank you very much for your time and help. Kind regards, (your name) (your email / phone with country code)
中文对照(供您核对)
尊敬的研究团队: 我是一位来自中国的患者,希望咨询参加以下临床试验的可能: 研究名称:OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion 试验编号:NCT07137832 申办方:Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 研究药物:Primary intra-arterial thrombolysis、Standard medical treatment 我的基本情况: - 年龄:(请填写) - 性别:(请填写) - 确诊疾病与分期:(请填写) - 基因/标志物检测:暂无 - 既往及当前治疗:(请填写) - 体能状态(ECOG):未评估 - 目前所在城市:中国 - 可前往范围:(请填写) 想请教三个问题: 1. 我是否可能符合本研究的入组标准? 2. 哪个中心对我最方便可行?能否远程预筛? 3. 预筛需要准备哪些资料(病历、病理、影像、近期化验)? 我可以提供英文翻译版病历。感谢您的时间与帮助。 顺祝安康 (您的姓名) (您的邮箱/带国际区号的电话)
提示:请与主治医生一起发信——由医生署名的申请,回复率远高于患者单独发信。首封邮件不要附身份证号等敏感信息。研究团队通常在 3–10 个工作日内回复,两周无回音可礼貌追问一次。
下一步怎么做?
- 把本页信息带给您的主治医生,评估是否适合参加。
- 点击下方按钮打开官方注册页,查看研究中心联系方式。
- 直接联系研究团队咨询报名事宜(通常有中文同声翻译服务可协助沟通)。